300254.SZ
Shanxi C&Y Pharmaceutical Group Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 7.86
+2.34%Margins
Gross margin
66.9%
EBITDA margin
15.5%
EBIT margin
7.9%
Net margin
2.1%
FCF margin
9.2%
4.0%
Return on equity
1.1%
Return on assets
8.2%
Return on invested capital
0.53x
Asset turnover
CNY 112.7M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026